Quarterly report pursuant to Section 13 or 15(d)

Significant Transactions (Details 1)

v3.21.2
Significant Transactions (Details 1) - Viridian Sciences [Member]
Apr. 02, 2021
USD ($)
Business Acquisition [Line Items]  
Accounts receivable $ 556
Prepaid expenses and other assets 148
Capitalized software 423
Acquired technology 470
Customer relationships 820
Acquired trade name 20
Goodwill 4,915
Accounts payable and accrued expenses (350)
Deferred revenue (1,000)
Net assets acquired $ 6,002